Why is Godavari Drugs falling/rising?

As of 25-Aug, Godavari Drugs Ltd is experiencing a decline in its stock price, currently at Rs 82.91, reflecting a decrease of Rs 0.5 or 0.6%. The stock has underperformed its sector by 1.66% today and has been on a downward trend, falling consecutively for the last two days with a total return of -2.13%. Despite opening with a gain of 3.11% and reaching an intraday high of Rs 86, the stock is trading below all its moving averages and is close to its 52-week low, indicating weak performance. Over the past year, the stock has generated a return of -19.19%, coinciding with a significant drop in profits by 41.2%. The company's weak long-term fundamentals, including a high Debt to EBITDA ratio and negative results for the last three consecutive quarters, further contribute to the stock's decline. In the broader market context, Godavari Drugs' short-term performance has been notably poor compared to the benchmark Sensex, which has gained 0.45% over the past week while the stock has dropped by 3.42%. This underperformance is indicative of the company's struggles, as it has consistently lagged behind the BSE500 over various time frames, including the last three years and one year. The stock's liquidity appears adequate for trading, but the overall sentiment remains negative due to the company's declining financial health and inability to service its debt effectively, leading to a lack of investor confidence.